- Anxiety
- Ascites, malignant
- Bleeding (Haemorrhage)
- Candidiasis, oral (Oral thrush)
- Constipation
- Cough
- Delirium (Confusion)
- Depression
- Diarrhoea
- Dry mouth (Xerostomia)
- Dyspepsia, reflux and peptic ulcers
- Dyspnoea (Breathlessness)
- Hiccup, refractory (Hiccough)
- Hypercalcaemia
- Hypersalivation
- Insomnia
- Intestinal obstruction
- Mouth care, general
- Mucositis
- Myoclonus (Myoclonic jerk, Seizure, Twitching)
-
Nausea and vomiting
- Complicated/resistant
- CTZ stimulation (uraemia, hypercalcaemia, drugs)
- Gastric stasis
- Hepatomegaly
- Higher centre stimulation (emotion - fear/anxiety)
- Intestinal obstruction
- Pharyngeal stimulation
- Vagal and sympathetic afferent stimulation
- Vestibular nerve stimulation (motion)
- Vomiting centre stimulation
- Nicotine withdrawal
-
Pain
- Bladder spasm
-
Bone pain
- Non-steroidal anti-inflammatory drugs (NSAIDs)
-
Opioids
- Buprenorphine - Injection
- Buprenorphine - Sublingual Tablet
- Buprenorphine - Transdermal Patch
- Fentanyl - Injection
- Fentanyl - Lozenge
- Fentanyl - Orodispersible Tablets
- Fentanyl - Patches
- Fentanyl - Sublingual Tablet
- Morphine hydrochloride
- Morphine sulfate
- Morphine tartrate
- Sufenta Forte (Sufentanyl (SAS))
- Disodium pamidronate
- Paracetamol
- Zoledronic acid
- Intestinal spasm
- Liver capsule pain
- Neuropathic pain
-
Nociceptive (soft tissue)
- Non-steroidal anti-inflammatory drugs (NSAIDs)
-
Opioids
- Alfentanil hydrochloride
- Buprenorphine - Injection
- Buprenorphine - Sublingual Tablet
- Buprenorphine - Transdermal Patch
- Codeine phosphate
- Fentanyl - Injection
- Fentanyl - Lozenge
- Fentanyl - Orodispersible Tablets
- Fentanyl - Patches
- Fentanyl - Sublingual Tablet
- Hydromorphone hydrochloride
- Methadone hydrochloride
- Morphine hydrochloride
- Morphine sulfate
- Morphine tartrate
- Oxycodone hydrochloride
- Oxycodone hydrochloride / Naloxone hydrochloride
- Sufenta Forte (Sufentanyl (SAS))
- Tramadol hydrochloride
- Ketamine hydrochloride
- Paracetamol
- Raised intracranial pressure
- Naloxone hydrochloride
- Pruritus (Itch)
- Respiratory secretions, excess (Noisy breathing, Terminal respiratory secretions)
- Seizures (Convulsions)
- Somnolence (Drowsiness, Sleepiness)
- Sweating
- Tenesmus
- Terminal restlessness (Refractory distress, Terminal agitation, Terminal sedation)
- Wound Care
- Alfentanil hydrochloride
- Alprazolam
- Amitriptyline hydrochloride
- Amphotericin B - Lozenge
- Antacids
- Atropine sulfate - Eye Drop
- Baclofen
- Benzodiazepines
- Benzydamine hydrochloride - Solution
- Biotene oralbalance (Saliva, Artificial)
- Bisacodyl
- Botulinum toxin type A
- Buprenorphine - Injection
- Buprenorphine - Sublingual Tablet
- Buprenorphine - Transdermal Patch
- Carbamazepine
- Carmellose sodium - Liquid
- Carmellose sodium / Gelatin / Pectin
- Celecoxib
- Chlorpromazine hydrochloride
- Cholestyramine
- Clonazepam
- Clonidine hydrochloride
- Codeine phosphate
- Cyclizine lactate
- Dexamethasone
- Diazepam
- Diclofenac sodium
- Disodium pamidronate
- Docusate sodium / Sennosides A and B
- Domperidone
- Duloxetine
- Esomeprazole
- Fentanyl - Injection
- Fentanyl - Lozenge
- Fentanyl - Orodispersible Tablets
- Fentanyl - Patches
- Fentanyl - Sublingual Tablet
- Flecainide acetate - Tablet
- Fluconazole
- Flunitrazepam
- Fluoxetine hydrochloride
- Frusemide
- Gabapentin
- Glycerol
- Glycopyrronium bromide (glycopyrrolate)
- Haloperidol
- Hydromorphone hydrochloride
- Hyoscine butylbromide
- Hyoscine hydrobromide
- Ibuprofen
- Ketamine hydrochloride
- Ketorolac trometamol
- Lactulose
- Lansoprazole
- Lignocaine - Transdermal Patch
- Lignocaine hydrochloride - Injection
- Loperamide hydrochloride
- Lorazepam
- Macrogol 3350 / Sodium chloride / Sodium bicarbonate / ...
- Meloxicam
- Methadone hydrochloride
- Methylnaltrexone bromide
- Methylphenidate hydrochloride
- Metoclopramide hydrochloride
- Metronidazole - Gel
- Miconazole - Oral gel
- Midazolam hydrochloride
- Mirtazapine
- Modafinil
- Morphine hydrochloride
- Morphine sulfate
- Morphine tartrate
- Mouth care
- Naloxone hydrochloride
- Naproxen
- Nicotine
- Nifedipine
- Nitrazepam
- Non-steroidal anti-inflammatory drugs (NSAIDs)
- Nortriptyline
- Nozinan (Levomepromazine (Methotrimeprazine) (SAS))
- Nystatin
- Octreotide
- Olanzapine
- Olive oil retention enema
- Omeprazole
- Ondansetron
- Oralube (Saliva, Artificial)
- Oxazepam
- Oxybutynin hydrochloride
- Oxycodone hydrochloride
- Oxycodone hydrochloride / Naloxone hydrochloride
- Pantoprazole
- Paracetamol
- Paraffin, liquid
- Phenobarbitone
- Phosphate enema
- Piroxicam
- Prednisolone
- Pregabalin
- Prochlorperazine maleate
- Promethazine hydrochloride
- Proton pump inhibitors (PPIs)
- Prucalopride
- Quetiapine fumarate
- Ranitidine - Concentrate for injection
- Risperidone
- Saliva stimulants
- Selective serotonin reuptake inhibitors (SSRIs)
- Sennosides A and B
- Sodium bicarbonate / Cetylpyridinium chloride / Ethanol
- Sodium citrate / Sodium lauryl sulfoacetate / Sorbitol
- Sodium valproate
- Spironolactone
- Sufenta Forte (Sufentanyl (SAS))
- Tapentadol
- Temazepam
- Tramadol hydrochloride
- Tranexamic acid
- Venlafaxine
- Zoledronic acid
UK Palliative Care Formulary (PCF5)
PCF5 How To Guide (for DHHS users only)
Eastern Metropolitan Region Palliative Care Consortium website
Scottish Palliative Care Guidelines
Gippsland Region Palliative Care Consortium
Fentanyl Key Pharmacokinetic Parameters for Approved Formulations for Breakthrough Pain
-
ABCBIATP-Binding Cassette sub-family B member 1
-
Acute care facilityRefers to the four major Tasmanian Public Hospitals; Royal Hobart Hospital, Launceston General Hospital, North-West Regional Hospital and the Mersey Community Hospital
-
AIDSAcquired Immune Deficiency Syndrome
-
Back titrationTechnique by which a physician slowly reduces the dose of a medication to determine the minimum effective dose in a particular patient
-
CABGCoronary Artery Bypass Graft
-
CNSCentral Nervous System
-
COPDChronic Obstructive Pulmonary Disease
-
COX InhibitorCyclo-oxygenase inhibitor
-
CSCIContinuous subcutaneous infusion
-
CSFCerebrospinal fluid
-
CTZChemoreceptor Trigger Zone
-
EPSEExtra-pyramidal side effects
-
For continued therapyThis medication is non-formulary for initiation of therapy but can be prescribed and supplied for inpatients and for up to one month on discharge if the patient was on the medication before admission. After the discharge supply has been exhausted the patient returns to their usual method of supply. STDC/TMAAC approval required for any initiation of inpatient therapy or non-PBS outpatient supply.
-
GIGastrointestinal
-
GITGastrointestinal tract
-
GORDGastric Oesophageal Reflux Disease
-
Guidance MSA DHHS online Antimicrobial Stewardship program being used to help assist in the appropriate selection of antimicrobial agents to help reduce the long term risk of antimicrobial resistance. See Guidelines and Other Resources to apply for patient approval
-
Highly Specialised Drugs ProgramFor approved indications for use see the PBS section of the drug monograph
-
Intrathecal AdministrationIntrathecal administration refers to the placement of medications into the fluid surrounding the spinal cord (the intrathecal space) for the purpose of analgesia or anaesthesia. This procedure requires specialist training. Please seek specialist advice.
-
LFTLiver Function Test
-
MAOIMonoamine oxidase inhibitors
-
MIMyocardial Infarction
-
NSAIDNon-steroidal anti-inflammatory drug
-
PBS IndicationsFor PBS eligible patients only. For approved indications for use see the PBS section of the drug monograph
-
PCFPalliative Care Formulary - UK reference for palliative care prescribing
-
PPIProton Pump Inhibitor
-
PUDPeptic Ulcer Disease
-
RPBSRepatriation Pharmaceutical Benefits Scheme
-
Rural Inpatient FacilityRefers to Tasmanian Rural Health Facilities: Beaconsfield District Health Service, Campbell Town Health and Community Service, Deloraine District Hospital, Esperance Multi-Purpose Centre, Flinders Island Multi Purpose Centre, George Town Hospital and Community Centre, King Island Hospital and Community Health Centre, North East Soldiers Memorial Hospital - Scottsdale, New Norfolk District Hospital, Midlands Multi-Purpose Health Centre - Oatlands, Rosebery Community Health Centre, Smithton District Hospital, St Helens District Hospital, St Marys Community Health Centre, Community Health Centre - Tasman, West Coast District Hospital - Queenstown
-
SASSpecial Access Scheme - allows access to non-TGA registered drugs
-
SIADHSyndrome of Inappropriate secretion of Anti-Diuretic Hormone
-
SNRISerotonin and Noradrenaline (Norepinephrine) Reuptake Inhibitor
-
SSRISelective Serotonin Reuptake Inhibitor
-
STDCStatewide Therapeutic Drug Committee. Now known as Tasmanian Medicines Access and Advisory Committee (TMAAC)
-
TCATricyclic antidepressant
-
TGATherapeutic Goods Administration- Please see MIMs indications for use below.
-
Therapeutic GuidelinesPlease see Global Resources for link to the Therapeutic Guidelines
-
THSTasmanian Health Service
-
TMAACTasmanian Medicines Access and Advisory Committee. Previously known as Statewide Therapeutic Drug Committee (STDC)
-
TMFTasmanian Medicines Formulary - the list of medications and indications available in the Tasmanian Health Service. Must be ordered by a practitioner with prescribing rights within the THS.
-
VTEVenous thromoembolism
Feedback and Queries:
Email: formulary@dhhs.tas.gov.au
UK Palliative Care Formulary (PCF5)
PCF5 How To Guide (for DHHS users only)
Eastern Metropolitan Region Palliative Care Consortium website
Scottish Palliative Care Guidelines
Gippsland Region Palliative Care Consortium
Fentanyl Key Pharmacokinetic Parameters for Approved Formulations for Breakthrough Pain
Feedback and Queries:
Email: formulary@dhhs.tas.gov.au
View Acknowledgements
The Tasmanian Palliative Care Formulary a resource for healthcare professionals who care for adult patients who require palliative care. This includes:
- Specialist Doctors
- General Practitioners
- Nurses
- Pharmacists
It is not intended as a resource for patients and carers. For quality evidence-based information for patients and carers, see www.caresearch.com.au/caresearch/tabid/64/Default.aspx
The Tasmanian Palliative Care Formulary includes:
- Medications with specialised palliative care indications
- Routes and dosing, including via syringe drivers
- Variations on usual prescribing for this patient group
- Summaries that compare medications within a class, eg. NSAIDs, benzodiazepines
- Links to useful resources;
- symptom management guidelines
- syringe driver compatibilities, and
- opioid conversion tables
It does not include information on paediatric, pregnant or breastfeeding patients. For these patients, please seek specialist resources and advice.
Navigation tips:
- To find what you are looking for, try using the search bar (above)
- Alternatively, use the tabs (left) to browse by symptom or drug, or to access useful links, glossary or guidelines
The ‘?’ button (top right) identifies these tabs, and for DHHS users, where to switch between the Tasmanian Palliative Care Formulary and the Tasmanian Medicines Formulary.
Please email formulary@dhhs.tas.gov.au for website support, feedback and comments.